Locations

Vancouver, WA, USA · North America · Seattle, WA, USA

industry

Biotechnology · Data and Analytics · DeepTech · Health · Software

Size

51-200 employees

Stage

Other

founded in

2011

Absci is a generative AI drug creation company focused on creating better biologics for patients faster. By leveraging deep learning AI and synthetic biology, Absci has developed an Integrated Drug Creation Platform that enables the design and validation of novel biologics, significantly reducing the time and cost associated with traditional drug discovery methods. The company partners with leaders in pharma, tech, and academia to tackle challenging targets, aiming to deliver life-changing medicines efficiently. With over 20 active programs and state-of-the-art facilities in multiple locations, Absci is positioned to revolutionize the biologics landscape and improve patient outcomes.

Something looks off?
Open jobs at AbSci

On-site & Remote